Usana Health Sciences (USNA) Equity Average (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Equity Average data on file, last reported at $538.3 million in Q2 2026.

• Equity Average for Q2 2026 came in at $538.3 million, up 1.39% year-over-year; the trailing twelve-month figure through Apr 2026 was $538.3 million (up 1.39% YoY), and the FY2026 annual result was $532.6 million, up 3.49% from the prior year.
• Equity Average climbed to $538.3 million in Q2 2026 per USNA's latest filing, from $530.6 million in the prior quarter.
• Over five years, Equity Average peaked at $538.3 million in Q2 2026 and troughed at $392.5 million in Q2 2022.
• A 5-year average of $477.6 million and a median of $491.2 million in 2023 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2023: Equity Average slipped 7.03% in 2022, then gained 16.45% in 2023.
• A 5-year view of Equity Average shows it stood at $422.8 million in 2022, then rose by 14.43% to $483.8 million in 2023, then climbed by 10.09% to $532.6 million in 2024, then slipped by 0.57% to $529.6 million in 2025, then increased by 1.65% to $538.3 million in 2026.
• Business Quant data shows USNA's Equity Average at $538.3 million in Q2 2026, $530.6 million in Q1 2026, and $529.6 million in Q3 2025.